Compass Therapeutics, Inc.

CMPX - Company ID 0001738021

Market cap-

Rank-

Filings347

Compass Therapeutics, Inc. has filed 347 public company documents between 2018 and 2026. The most frequent type is insider trade (112 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.

Continue researchCMPX overviewCompany snapshotMarket cap, financials, charts, and latest company context.

Continue researchMarket cap historyLive rankingSee the market value trend behind the filing history.

Continue researchRevenue trendAnnual historyMove from documents into filing-backed operating results.

Continue researchCompare with AMGNPeer viewPut CMPX beside AMGN across market cap, revenue, income, and filings.

Browse latest filings across all companies →Follow CMPX via RSS

Similar companies to research next

AMGNAmgen Inc.

GILDGilead Sciences, Inc.AARGXargenx SE RRVMDRevolution Medicines, Inc.

BIIBBiogen Inc.

MRNAModerna, Inc.

Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.

Type	Filing	Filed	Period covered	Open
10-K	Annual report	4mo ago2026-03-05	2025-12-31	View filing
10-K	Annual report	1y ago2025-02-27	2024-12-31	View filing
10-K	Annual report	2y ago2024-03-21	2023-12-31	View filing
10-K	Annual report	3y ago2023-03-15	2022-12-31	View filing
10-K	Annual report	4y ago2022-03-18	2021-12-31	View filing
10-K	Annual report	5y ago2021-03-05	2020-12-31	View filing
10-K	Annual report	6y ago2020-06-08	2020-03-31	View filing
10-K	Annual report	7y ago2019-07-01	2019-03-31	View filing

Compass Therapeutics, Inc.

Similar companies to research next

Year